WallStreetZenWallStreetZen

NASDAQ: RIGL
Rigel Pharmaceuticals Inc Stock Ownership - Who owns Rigel Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rigel Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dean L. SchornoEVP Chief Financial Officer2026-02-103,546$34.62
$122.76kSell
Raymond J. FureyEVP GC CCO Corp Sec2026-02-103,546$34.62
$122.76kSell
Raul R. RodriguezCEO President2026-02-107,607$34.62
$263.35kSell
Lisa RojkjaerEVP Chief Medical Officer2026-02-103,758$34.62
$130.10kSell
David A. SantosEVP Chief Commercial Officer2026-02-103,546$34.62
$122.76kSell
David A. SantosEVP Chief Commercial Officer2026-02-025,718$36.01
$205.91kSell
Raul R. RodriguezCEO President2026-02-0214,110$36.01
$508.10kSell
Raymond J. FureyEVP GC CCO Corp Sec2026-02-023,968$36.01
$142.89kSell
Dean L. SchornoEVP Chief Financial Officer2026-02-025,488$36.01
$197.62kSell
Raul R. RodriguezCEO President2026-01-2640,000$27.40
$1.10MBuy

1 of 2

RIGL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RIGL insiders and whales buy or sell their stock.

RIGL Shareholders

What type of owners hold Rigel Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P91.78%16,660,120$571.78MInsider
James E. Flynn37.14%6,742,289$231.40MInsider
Blackrock Inc9.17%1,664,210$57.12MInstitution
State Street Corp6.01%1,091,223$37.45MInstitution
Vanguard Group Inc5.72%1,038,408$35.64MInstitution
Goldman Sachs Group Inc3.70%671,878$23.06MInstitution
Marshall Wace LLP3.38%613,600$21.06MInstitution
Lsv Asset Management3.00%544,282$18.68MInstitution
Renaissance Technologies LLC2.97%539,009$18.50MInstitution
Acadian Asset Management LLC2.72%493,604$16.94MInstitution

1 of 3

RIGL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RIGL32.71%67.29%Net SellingNet Selling
DRTS2.19%0.00%
MGTX45.37%54.63%Net SellingNet Selling
PRME36.45%63.51%Net Buying
PROK7.82%39.20%Net Buying
View Top Biotech Stocks

Rigel Pharmaceuticals Stock Ownership FAQ

Who owns Rigel Pharmaceuticals?

Rigel Pharmaceuticals (NASDAQ: RIGL) is owned by 66.29% institutional shareholders, 136.36% Rigel Pharmaceuticals insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Rigel Pharmaceuticals shareholder, owning 16.66M shares representing 91.78% of the company. Bvf Partners L P's Rigel Pharmaceuticals shares are currently valued at $571.78M.

If you're new to stock investing, here's how to buy Rigel Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.